Lantidra – Allogeneic islet transplant

Despite technological advances in intensive insulin therapy (i.e. pumps, sensors, continuous glucose monitors), patients with brittle type I diabetes may continue to experience hypoglycemic unawareness and life-threatening hypoglycemic episodes. Islet cell transplantation can prevent severe hypoglycemic episodes and improve glycemic control. Allogeneic islet transplantation is safe, effective, and minimally invasive with proven outcomes, fewer complications, and similar overall costs to whole pancreas transplants.

Autologous islet transplant

Patients suffering from chronic pancreatitis can benefit from a partial resection or total pancreatectomy with an autologous islet cell transplant.

Benefits include reduction in exogenous insulin and maintenance of normoglycemia. This complex procedure requires specialized expertise and trained personnel with access to a certified islet isolation facility.